Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

(Reuters) - State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China drug distribution business for $557 million, as it seeks to expand its distribution and retail network nationwide.